Carl Zeiss Meditec AG achieves significant growth in revenue and profit in fiscal year 2018/19
Contact for investors and press Sebastian Frericks Director Investor Relations Carl Zeiss Meditec AG Tel.: +49 3641 220-116 E-Mail: email@example.com
 Currency-adjusted sales growth is determined by weighing sales in the comparative period with current instead of actual historical exchange rates. Earnings before interest and taxes (also operating profit, EBIT) refers to a key earnings figure within the Carl Zeiss Meditec Group and is calculated in accordance with IFRS standards (see Annual Report 2017/18, p. 76 for reconciliation). Calculation: EBIT margin = EBIT / revenue (in %) (see Annual Report 2017/18, p. 76).
02-Oct-2019 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.deLanguage: English Company: Carl Zeiss Meditec AG Göschwitzer Str. 51-52 07745 Jena
Germany Phone: +49 (0)3641 220-0 Fax: +49 (0)3641 220-112 E-mail: firstname.lastname@example.org Internet: www.zeiss.de/meditec-ag/ir ISIN: DE0005313704 WKN: 531370 Indices: MDAX, TecDAX Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange EQS News ID: 884075 End of Announcement DGAP News Service
884075 02-Oct-2019 CET/CEST